{
  "id": 8055362,
  "title": "A Biotech Company Had $268 Million in Cash. After a Failed Drug Trial, It Announced a 46 Percent Workforce Cut",
  "url": "https://urgent.news/2026/09/17/a-biotech-company-had-268-million-in-cash-after-a-failed-drug-trial",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-17T16:08:21.000Z",
  "source": {
    "name": "Inc.",
    "slug": "inc",
    "url": "https://www.inc.com/lucia-auerbach/biotech-company-268-million-dollars-in-cash-after-failed-drug-trial-46-percent-workforce-cut/91406570"
  },
  "original_language": "en",
  "account": null,
  "summary": "The biotech company is downsizing to fund another trial after a drug showed no meaningful benefit. The move comes just a year after its IPO.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}